People with sickle cell disease who receive nonmyeloablative stem cell transplants are at greater risk for developing new tumors, according to a new study published in the Journal of Clinical Oncology.
Mar 9, 2023
0
2
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows a relationship between genotype, bone marrow failure and survival in patients with the rare autoinflammatory ...
Nov 1, 2021
0
3
Biju Parekkadan saw his future in the plight of a newborn thousands of miles away.
Sep 3, 2012
0
0
St. Jude Children's Research Hospital investigators have identified a new form of an immune cell that protected mice from life-threatening lung infections under conditions that mimic cancer chemotherapy. The research appears ...
Sep 26, 2016
0
27
Researchers developed a new type of cell transplantation to treat mice mimicking a rare lung disease that one day could be used to treat this and other human lung diseases caused by dysfunctional immune cells.
Oct 1, 2014
0
0
The first clinical trial of a new vaccine for visceral leishmaniasis (VL) has been launched by the Infectious Disease Research Institute (IDRI), a Seattle-based nonprofit that develops products to prevent, detect, and treat ...
Feb 23, 2012
0
0
A team of researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore, led by Associate Professor Takaomi Sanda and Dr. Lim Fang Qi, has breathed new life into an existing ...
Jan 30, 2023
0
7
The European Society for Blood and Marrow Transplantation (EBMT), Europe's collaborative peer network of professionals working in the field of stem cell transplantation and cellular therapy, announced today the results of ...
Aug 31, 2020
0
6
French pharmaceutical giant Sanofi announced on Wednesday its second acquisition of a US firm in as many months, buying transplant drug company Kadmon for $1.9 billion (1.6 billion euros).
Sep 8, 2021
0
3
Researchers at the University of Michigan Health Rogel Cancer Center have identified a drug that, when given along with a bone marrow transplant, drops the risk of leukemia recurring by 20% among the high-risk patients.
Oct 20, 2021
0
6
